Mutation of anti-angiogenic sequences in the type I repeats of thrombospondin-1

被引：0
|
作者：
Chandrasekaran, L [1 ]
Roberts, DD [1 ]
机构：
[1] NCI, Pathol Lab, NIH, Bethesda, MD 20892 USA
来源：
MOLECULAR BIOLOGY OF THE CELL | 1998年 / 9卷
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
1732
引用
收藏
页码：298A / 298A
页数：1
相关论文
共 50 条
  • [21] Induction of thrombospondin-I partially mediates the anti-angiogenic activity of dexrazoxane
    Maloney, S. L.
    Sullivan, D. C.
    Suchting, S.
    Herbert, J. M. J.
    Rabai, E. M.
    Nagy, Z.
    Barker, J.
    Sundar, S.
    Bicknell, R.
    BRITISH JOURNAL OF CANCER, 2009, 101 (06) : 957 - 966
  • [22] Inducer-stimulated Fas targets activated endothelium for destruction by anti-angiogenic thrombospondin-1 and pigment epithelium–derived factor
    Olga V. Volpert
    Tetiana Zaichuk
    Wei Zhou
    Frank Reiher
    Thomas A. Ferguson
    P. Michael Stuart
    Mohammad Amin
    Noel P. Bouck
    Nature Medicine, 2002, 8 : 349 - 357
  • [23] Inducer-stimulated Fas targets activated endothelium for destruction by anti-angiogenic thrombospondin-1 and pigment epithelium derived factor
    Volpert, OV
    Zaichuk, T
    Zhou, W
    Reiher, F
    Ferguson, TA
    Stuart, PM
    Amin, M
    Bouck, NP
    NATURE MEDICINE, 2002, 8 (04) : 349 - 357
  • [24] Identification of novel β1 integrin binding sites in the type 1 and type 2 repeats of thrombospondin-1
    Calzada, MJ
    Annis, DS
    Zeng, BX
    Marcinkiewicz, C
    Banas, B
    Lawler, J
    Mosher, DF
    Roberts, DD
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (40) : 41734 - 41743
  • [25] Thrombospondin-1 proteomimetic polymers exhibit anti-angiogenic activity in a neovascular age-related macular degeneration mouse model
    Choi, Wonmin
    Nensel, Ashley K.
    Droho, Steven
    Fattah, Mara A.
    Mokashi-Punekar, Soumitra
    Swygart, David I.
    Burton, Spencer T.
    Schwartz, Greg W.
    Lavine, Jeremy A.
    Gianneschi, Nathan C.
    SCIENCE ADVANCES, 2023, 9 (41)
  • [26] Regulation of nitric oxide signalling by thrombospondin 1: implications for anti-angiogenic therapies
    Isenberg, Jeff S.
    Martin-Manso, Gema
    Maxhimer, Justin B.
    Roberts, David D.
    NATURE REVIEWS CANCER, 2009, 9 (03) : 182 - 194
  • [27] Regulation of nitric oxide signalling by thrombospondin 1: implications for anti-angiogenic therapies
    Jeff S. Isenberg
    Gema Martin-Manso
    Justin B. Maxhimer
    David D. Roberts
    Nature Reviews Cancer, 2009, 9 : 182 - 194
  • [28] Thrombin-reduced miR-27b attenuates platelet angiogenic activities in vitro via enhancing platelet synthesis of anti-angiogenic thrombospondin-1
    Miao, X.
    Rahman, M. F. -U.
    Jiang, L.
    Min, Y.
    Tan, S.
    Xie, H.
    Lee, L.
    Wang, M.
    Malmstrom, R. E.
    Lui, W. -O.
    Li, N.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2018, 16 (04) : 791 - 801
  • [29] Preclinical anti-tumor efficacy of ABT-510 (thrombospondin-1 mimetic peptide), a novel anti-angiogenic agent, in hematological malignancies.
    Cikojevic, A
    Wang, ES
    BLOOD, 2005, 106 (11) : 681A - 681A
  • [30] Treatment with a Combination of Metformin and 2-Deoxyglucose Upregulates Thrombospondin-1 in Microvascular Endothelial Cells: Implications in Anti-Angiogenic Cancer Therapy
    Samuel, Samson Mathews
    Satheesh, Noothan Jyothi
    Ghosh, Suparna
    Busselberg, Dietrich
    Majeed, Yasser
    Ding, Hong
    Triggle, Chris R.
    CANCERS, 2019, 11 (11)
12345